167 related articles for article (PubMed ID: 24762620)
1. Constitutional promoter methylation and risk of familial melanoma.
Hyland PL; Burke LS; Pfeiffer RM; Rotunno M; Sun D; Patil P; Wu X; Tucker MA; Goldstein AM; Yang XR
Epigenetics; 2014 May; 9(5):685-92. PubMed ID: 24762620
[TBL] [Abstract][Full Text] [Related]
2. LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.
Hyland PL; Burke LS; Pfeiffer RM; Mirabello L; Tucker MA; Goldstein AM; Yang XR
Melanoma Res; 2013 Feb; 23(1):55-60. PubMed ID: 23222549
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines.
Cai HH; Sun YM; Miao Y; Gao WT; Peng Q; Yao J; Zhao HL
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):95-100. PubMed ID: 21269942
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
Cheng Y; Kim JW; Liu W; Dunn TA; Luo J; Loza MJ; Kim ST; Zheng SL; Xu J; Isaacs WB; Chang BL
Prostate; 2009 Feb; 69(3):327-35. PubMed ID: 19035483
[TBL] [Abstract][Full Text] [Related]
5. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
[TBL] [Abstract][Full Text] [Related]
6. Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L; Favero C; Pfeiffer RM; Tarantini L; Calista D; Cavalleri T; Angelici L; Consonni D; Bertazzi PA; Pesatori AC; Landi MT; Bollati V
Melanoma Res; 2014 Oct; 24(5):480-7. PubMed ID: 25026000
[TBL] [Abstract][Full Text] [Related]
7. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of constitutional DNA methylation in familial melanoma.
Salgado C; Gruis N; ; Heijmans BT; Oosting J; van Doorn R
Clin Epigenetics; 2020 Mar; 12(1):43. PubMed ID: 32143689
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations in sporadic basal cell carcinomas.
Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
[TBL] [Abstract][Full Text] [Related]
10. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
11. Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma.
Ghiorzo P; Gargiulo S; Pastorino L; Nasti S; Cusano R; Bruno W; Gliori S; Sertoli MR; Burroni A; Savarino V; Gensini F; Sestini R; Queirolo P; Goldstein AM; Scarrà GB
Hum Mol Genet; 2006 Sep; 15(18):2682-9. PubMed ID: 16893909
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
Buecher B; Gauthier-Villars M; Desjardins L; Lumbroso-Le Rouic L; Levy C; De Pauw A; Bombled J; Tirapo C; Houdayer C; Bressac-de Paillerets B; Stoppa-Lyonnet D
Fam Cancer; 2010 Dec; 9(4):663-7. PubMed ID: 20842456
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH
J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325
[TBL] [Abstract][Full Text] [Related]
14. Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?
Di Lorenzo S; Fanale D; Corradino B; Caló V; Rinaldi G; Bazan V; Giordano A; Cordova A; Russo A
Cancer Biol Ther; 2016; 17(1):83-90. PubMed ID: 26650572
[TBL] [Abstract][Full Text] [Related]
15. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract][Full Text] [Related]
17. Frequent p16-independent inactivation of p14ARF in human melanoma.
Freedberg DE; Rigas SH; Russak J; Gai W; Kaplow M; Osman I; Turner F; Randerson-Moor JA; Houghton A; Busam K; Timothy Bishop D; Bastian BC; Newton-Bishop JA; Polsky D
J Natl Cancer Inst; 2008 Jun; 100(11):784-95. PubMed ID: 18505964
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations.
de Araújo É; Marchi FA; Rodrigues TC; Vieira HC; Kuasne H; Achatz MI; Moredo LF; de Sá BC; Duprat JP; Brentani HP; Rosenberg C; Carraro DM; Krepischi AC
Exp Mol Pathol; 2014 Dec; 97(3):425-32. PubMed ID: 25236571
[TBL] [Abstract][Full Text] [Related]
19. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
